Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Arcutis Biotherapeutics (ARQT) Leases (2020 - 2025)

Arcutis Biotherapeutics (ARQT) has 6 years of Leases data on record, last reported at $4.5 million in Q4 2025.

  • For Q4 2025, Leases rose 128.73% year-over-year to $4.5 million; the TTM value through Dec 2025 reached $4.5 million, up 128.73%, while the annual FY2025 figure was $4.5 million, 128.73% up from the prior year.
  • Leases reached $4.5 million in Q4 2025 per ARQT's latest filing, down from $4.6 million in the prior quarter.
  • Across five years, Leases topped out at $4.6 million in Q3 2025 and bottomed at $1.7 million in Q2 2025.
  • Average Leases over 5 years is $2.8 million, with a median of $2.7 million recorded in 2022.
  • Peak YoY movement for Leases: surged 1346.46% in 2021, then decreased 20.11% in 2025.
  • A 5-year view of Leases shows it stood at $3.0 million in 2021, then dropped by 10.49% to $2.7 million in 2022, then fell by 13.23% to $2.4 million in 2023, then dropped by 17.28% to $2.0 million in 2024, then soared by 128.73% to $4.5 million in 2025.
  • Per Business Quant database, its latest 3 readings for Leases were $4.5 million in Q4 2025, $4.6 million in Q3 2025, and $1.7 million in Q2 2025.